DUSA Pharmaceuticals (NASDAQ: DUSA), a fully integrated specialty pharmaceutical company, is primarily focused on the development and marketing of its Levulan® photodynamic therapy (PDT) technology platform used in conjunction with its proprietary light source, the BLU-U® Blue Light Photodynamic Therapy Illuminator. Its Levulan Kerastick® for Topical Solution, 20% in combination with the BLU-U, is FDA-approved for the treatment of minimally to moderately thick actinic keratoses (AKs) of the face or scalp. DUSA® also markets other dermatology products. For more information visit the company’s Web site at www.dusapharma.com

Marcum offers an extensive range of professional services and a high degree of specialization. In addition to traditional accounting, assurance, and tax, including domestic and international tax planning and preparation, the firm’s professional services include mergers and acquisition planning, family office services, forensic accounting, and litigation support. For more information on Marcum, visit www.marcumllp.com

Let us hear your thoughts below: